Anti-inflammatory effects of specific cyclooxygenase 2,5-lipoxygenase, and inducible nitric oxide synthase inhibitors on experimental autoimmune anterior uveitis (EAAU)

Ocular Immunology and Inflammation

Volumn 13, Issue 2-3, 2005, Pages 183-189

  Bora, Nalini S ^a   Sohn, Jeong Hyeon ^a   Bora, Puran S ^a   Kaplan, Henry J ^a   Kulkarni, Prasad ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

5 LP inhibitor; COX 2 inhibitor; EAUU; Eicosanoids; iNOS inhibitor; Nitric oxide

Indexed keywords

AMINOGUANIDINE; CS 236; CYCLOOXYGENASE 2 INHIBITOR; LIPOXYGENASE INHIBITOR; NITRIC OXIDE SYNTHASE INHIBITOR; NORDIHYDROGUAIARETIC ACID; UNCLASSIFIED DRUG; ARACHIDONATE 5 LIPOXYGENASE; CELECOXIB; CYCLOOXYGENASE 2; GUANIDINE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CILIARY BODY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HISTOPATHOLOGY; IMMUNIZATION; IRIS; MALE; NONHUMAN; RAT; SLIT LAMP; TREATMENT OUTCOME; UVEITIS; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG ANTAGONISM; ENZYMOLOGY; FOLLOW UP; IMMUNOLOGY; IRIDOCYCLITIS; LEWIS RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; AUTOIMMUNE DISEASES; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FOLLOW-UP STUDIES; GUANIDINES; INJECTIONS, SUBCUTANEOUS; LIPOXYGENASE INHIBITORS; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NORDIHYDROGUAIARETIC ACID; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, INBRED LEW; SULFONAMIDES; TREATMENT OUTCOME; UVEITIS, ANTERIOR;

EID: 25144442376     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940590928643     Document Type: Article

References (40)

1. Masferrer JL, Kulkarni PS. Cyclooygenase-2 inhibitors: a new approach to the therapy of ocular inflammation. Ophthalmol Surv. 1995;41:535-540.
2. Chiou GCY. Review. Effects of nitric oxide on eye diseases and their treatment. J Ocul Pharmacol. 2001;17(2):189-196.
3. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
4. Bito LZ, Camaras CB, Gum GG, Resul B. The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals. In: Bito LZ, Stiernschantz J, editors. The ocular effects of prostaglandins and other eicosanoids. New York: Alan R Liss, Inc., 1989; 349-368.
5. Luckhart S, Rosenberg R. Gene structure and polymorphism of an invertebrate nitric oxide synthase gene. Gene. 1999;232:25-34.
6. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357:593-615.
7. Weinberg JB. Nitric oxide-2 and cyclooxygenase-2 interaction in inflammation. Immunogenic Res. 2001;22:319-341.
8. Masferrer JL, Zweifel BS, Hauser S, Seibert K, Needleman P. Selective inhibition of inducible cyclooxygenase-2 in vivo is anti-inflammatory and non-ulcerogenic. Proc Natl Acad Sci USA. 1994;91:3228-3232.
9. Mahlberg K, Uusitalo R, Uusitalo H, Palkama A, Tallberg T. Suppression of experimental autoimmune uveitis in guinea-pigs by inhibition of phospholipase A2. J Ocul Pharmacol. 1987;3(3):199-210.
10. Kulkarni PS, Srinivasan BD. Nonsteroidal anti-inflammatory drugs in ocular inflammatory conditions. In: Lewis AJ, Furst DE, editors. Non-steroidal anti-inflammatory drugs. New York, Basel: Marcel Dekker, Inc., 1987;107-125.
11. Fleisher LN. Effects of inhibitors of arachidonic acid metabolism on endotoxin-induced ocular inflammation. Curr Eye Res. 1988;7(3):321-327.
12. Kulkarni PS. The role of endogenous eicosanoids in rabbit-intraocular inflammation. J Ocul Pharmacol. 1991;7(3):227-241.
13. Mahlberg K, Uusitalo H, Palkama A, TallbergT. Correlation between histopathological, clinical and biochemical parameters in S-antigen-induced experimental autoimmune uveitis in guinea-pigs. Exp Eye Res. 1987;45(1):157-167.
14. Mahlberg K, Uusitalo R, Palkama A, Tallberg T. Phospholipase A2, leukotriene C4 and prostaglandin E2 levels in aqueous humor of guinea pigs with experimental S-antigen induced autoimmune uveitis. Curr Eye Res. 1987;6(2):321-335.
15. Srinivasan BD, Kulkarni PS. The effect of steroidal and nonsteroidal anti-inflammatory agents on corneal reepithelialization. Invest Ophthalmol Vis Sci. 1981;20(5):688-691.
16. Srinivasan BD, Kulkarni PS. Polymorphonuclear leukocyte response: inhibition following corneal epithelial denudation by steroidal and nonsteroidal anti-inflammatory agents. Arch Ophthalmol. 1981;99:1085-1089.
17. Kulkarni PS, Bhattacherjee P, Eakins KE, Srinivasan BD. Anti-inflammatory effects of betamethasone phosphate, dexamethasone phosphate and indomethacin on rabbit ocular inflammation induced by bovine serum albumin. Curr Eye Res. 1981;1(1):43-47.
18. Kulkarni PS, Bhattacherjee P, Paterson C. Dexamethasone inhibits the release of rabbit interleukin-1 endotoxin-uveitis model in rabbits. Exp Eye Res. 1994;58:637-638.
19. Kulkarni PS, Paterson CA. Diclofenac and prednisolone inhibit endotoxin induced uveitis in rabbits. Exp Eye Res. 1995;61:767-768.
20. Bellot JL, Palmero M, Garcia-Cabanes C, Espi R, Hariton C, Orts A. Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit. Inflamm Res. 1996;45(4):203-208.
21. Bellot JL, Palmero M, Alcoriza N, et al. Concomitant treatment with a 5-lipoxygenase inhibitor improves the anti-inflammatory effect of the inhibition of nitric oxide synthase during the early phase of endotoxin-induced uveitis in the rabbit. Ophthalmic Res. 1997;29(4):227-236.
22. Parks DJ, Cheung MK, Chan CC, Roberge FG. The role of nitric oxide in uveitis. Arch Ophthalmol. 1994;112(4):544-546.
23. Allen JB, McGahan MC, Ferrell JB, Adler KB, Fleisher LN. Nitric oxide synthase inhibitors exert differential time-dependent effects on LPS-induced uveitis. Exp Eye Res. 1996;62(1):21-28.
24. Goureau O, Bellot J, Thillaye B, Courtois Y, de Kozak Y. Increased nitric oxide production in endotoxin-induced uveitis. Reduction of uveitis by an inhibitor of nitric oxide synthase. J Immunol. 1995;154(12):6518-6523.
25. Tilton RG, Chang K, Corbett JA, et al. Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest Ophthalmol Vis Sci. 1994;35(8):3278-3288.
26. Matteson DM, Shen DF, Chan CC. Inhibition of experimental melanin protein-induced uveitis (EMIU) by targeting nitric oxide via phosphatidylcholine-specific phospholipase C. J Autoimmun. 1999;13(2):197-204.
27. Mandai M, Mittag TW, Kogishi J, Iwaki M, Hangai M, Yoshimura N. Role of nitric oxide synthase isozymes in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 1996;37(5):826-832.
28. Smith JR, Hart PH, Standfield SD, Coster DJ, Wing SJ, Williams KA. Apoptosis is a prominent feature of acute anterior uveitis in the Fischer 344 rat. Br J Ophthalmol. 2000;84:205-211.
29. Chen F, Pararajasegaram G, Sevanian A, Rao NA. Treatment of S antigen uveoretinitis with lipoxygenase and cyclooxygenase inhibitors. Ophthalmic Res. 1991;23(2):84-91.
30. Broekhuyse RM, Kuhlman ED, Winkens HJ, Van Vugt AH. Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis. I. Induction by a detergent-insoluble, intrinsic protein fraction of the retina pigment epithelium. Exp Eye Res. 1991;52:465-474.
31. Nussenblatt RB, Whitcup SM, Palestine AG. Uveitis: fundamentals and clinical practice. St. Louis, MO: Mosby, 1996; 413 pp.
32. Bora NS, Kim MC, Kabeer NH, Simpson SC, Tandhasetti MT, Cirrito TP, Kaplan AD, Kaplan HJ. Experimental autoimmune anterior uveitis (EAAU): induction with melanin associated antigen from the iris and ciliary body. Invest. Ophthalmol Vis Sci. 1995;36:1056-1066.
33. Kim MC, Kabeer NH, Tandhasetti MT, Kaplan HJ, Bora NS. Immunohistochemical studies in melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU). Curr Eye Res. 1995;4:703-710.
34. Bora NS, Woon MD, Tandhasetti MT, Cirrito TP, Kaplan HJ. Induction of experimental autoimmune anterior uveitis by a self-antigen: melanin complex without adjuvant. Invest Ophthalmol Vis Sci. 1997;38:2171-2175.
35. Gierse JK, McDonald JJ, Hauser SD, Rangwala SH, Koboldot CM, Seibert K. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2(COX-2) reverses the selectivity of COX-2 specific inhibitors. J Biol Chem. 1996;271:15810-15814.
36. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA. 1994;91:12013-12017.
37. Jaramillo A, Bhattacherjee P, Sonnenfeld G, Paterson CA. Modulation of immune responses by cyclo-oxygenase inhibitors during intraocular inflammation. Curr Eye Res. 1992;11(6):571-579.
38. Sand BB, Krough E. Topical indomethacin, a prostaglandin inhibitor, in acute anterior uveitis. A controlled clinical trial of non-steroid versus steroid anti-inflamatory treatment. Acta Ophthalmol. 1991;69:145-148.
39. Crooks SW, Stockley RA. Leukotriene B4. Int J Biochem Cell Biol. 1998;30:173-178.
40. Smith JR, Hart PH, Coster DJ, Williams KA. Mice deficient in tumor necrosis factor receptors p55 and p75, interlukin-4, or inducible nitric oxide synthase are susceptible to endotoxin induced uveitis. Invest Ophthalmol Vis Sci. 1998;39:658-661.